Related Experiment Videos
[ABO compatibility and isoimmune neonatal thrombopenia]
Schweizerische Medizinische Wochenschrift
|October 15, 1977
Summary
Isoimmune neonatal thrombopenia requires ABO-compatible mothers and infants. This suggests fetal platelets possess ABO-antigens, necessitating feto-maternal ABO compatibility for this condition to develop.
Area of Science:
- Immunology
- Hematology
- Neonatal Medicine
Context:
- Investigated 25 families with serologically confirmed isoimmune neonatal thrombopenia.
- Examined ABO-antigen compatibility between mothers and their affected infants.
Purpose:
- To determine the role of ABO-antigen compatibility in the development of isoimmune neonatal thrombopenia.
- To elucidate the mechanism by which feto-maternal ABO compatibility influences neonatal thrombopenia.
Summary:
- In all 25 families studied, mothers and infants were ABO-compatible.
- This ABO compatibility was found to be a prerequisite for the development of isoimmune neonatal thrombopenia.
Impact:
- Suggests that platelets possess ABO-antigens or are coated with soluble ABO-antigens.
- Highlights the critical role of feto-maternal ABO compatibility in neonatal alloimmune thrombocytopenia pathogenesis.